NCT06922695 - Responding to AF: Pill-in-Pocket Anticoagulation Guided by Automated Monitoring and Alerts | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 14, 2025

Primary Completion Date

April 15, 2027

Study Completion Date

April 15, 2027

Conditions

Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)

Interventions

OTHER

Pill-in-pocket anticoagulation

Participants will stop their oral anticoagulation after a 30-day period free of AF episodes. After this, they will only take their anticoagulation in response to an episode of AF detected by their implantable cardiac monitor. The participants will receive an automated smartphone alert instructing them to commence their anticoagulation as soon as AF is detected.

Trial Locations (1)

OX3 9DU

RECRUITING

Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Oxford